Solutions
Online Inquiry
Global Services. (Creative Biolabs Authorized)

Polyclonal CD3⁺ T Cell based Artificial T Cell Stimulator Development Service

Online Inquiry

Background

CD3 is a vital protein complex found on the surface of most T cells, acting as a coreceptor that facilitates their activation. This activation process is crucial for the expansion and function of both CD4+ helper T cells and CD8+ cytotoxic T cells, key players in the immune response against infections, cancer, and autoimmune diseases. By effectively activating CD3+ T cells, immunotherapy strategies aim to enhance the immune system's ability to combat these threats, offering promising avenues for clinical advancements.

Fig.1 Schematic diagram of DN T cell origin and distribution.Fig.1 Diagram depicting CD3+CD4-CD8- (Double-Negative) T cell origin and dissemination.1,3

Polyclonal CD3+ T Cell based Artificial T Cell Stimulator Development Service at Creative Biolabs

Creative Biolabs provides a complete set of polyclonal CD3+ T cell-based artificial T cell stimulator development services, aiming to accelerate the development of CD3+ T cell immunotherapy. Our service covers the entire process from artificial T cell stimulator platform construction, T cell activation optimization to T cell function characterization. By adopting advanced cell engineering technology and a strict quality control system, we can quickly and efficiently build high-performance artificial T cell stimulators to achieve precise activation and expansion of polyclonal CD3+ T cells. In addition, we also provide customized experimental design and data analysis services to meet the personalized needs of our customers. Our goal is to work closely with our customers to jointly promote the clinical application of CD3+ T cell immunotherapy.

Attractive Features

  • Comprehensive services: Our service covers all aspects of artificial T cell stimulator development, including platform construction, optimization, and characterization.
  • High-quality assurance: We apply advanced technology and strict quality control to ensure smooth service and high-quality results.
  • Efficient results delivery: We are confident in delivering customers' desired results in a short turnaround time.
  • Customized services: We can personalize experimental design and data analysis to satisfy customers' various needs.

Data Display

This research seeks to clarify how human CD4+ T cells support the proliferation of CD8+ T cells through a newly established in vitro model. The team has designed a novel artificial T cell stimulator. Findings indicate that this artificial T cell stimulator can promote comprehensive expansion of CD3+ T cells without the need for allogeneic feeder cells. Additionally, the stimulation of CD3+ T cells with the artificial T cell stimulator leads to significant enhancement of CD8+ T cell proliferation.

Fig.2 Artificial T cell stimulator/mOKT3 induces unbiased CD3+ T cell expansion.Fig.2 Unbiased CD3+ T cell expansion stimulated by the engineered artificial T cell stimulator.2,4

Associated Services

Creative Biolabs provides an extensive array of tailored artificial T cell stimulator development services, not only for polyclonal CD3+ T cells but also for various immune cell types. Our offerings encompass the customization of artificial T cell stimulators for CD4+ T cells, CD8+ T cells, CAR-T cells, NK cells, and more. This diverse range enhances our capability to support a broad spectrum of immunological research and therapeutic applications, ensuring that we meet the specific needs of our clients in advancing their projects.

Q & A

Q1: What are the typical steps involved in this service?

A1: Developing artificial T cell stimulators for polyclonal CD3+ T cell activation involves engineering platforms to express key molecules. This is followed by optimizing conditions to maximize T cell activation and expansion using these engineered artificial T cell stimulators. Finally, the activated T cells are rigorously characterized to assess their quality and functionality, including cytokine production and cytotoxic activity.

If you want to develop an ideal artificial T cell stimulator for stimulating CD3+ T cells, please click the link to reach out to us.

References

  1. Wu, Zhiheng, et al. "CD3+ CD4-CD8-(Double-negative) T cells in inflammation, immune disorders and cancer." Frontiers in Immunology 13 (2022): 816005.
  2. Butler, Marcus O., et al. "Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help." PloS one 7.1 (2012): e30229.
  3. Distributed under Open Access License CC BY 4.0, without modification.
  4. Distributed under Open Access License CC BY, without modification.
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.